Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ardelyx Inc. (ARDX)

8.02   -0.77 (-8.76%) 02-21 16:00
Open: 8.77 Pre. Close: 8.79
High: 8.77 Low: 7.925
Volume: 1,430,234 Market Cap: 528M
Ardelyx Inc is a clinical stage biopharmaceutical company. It engages in the discovery, development and commercialization of non-systemic, molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal and metabolic diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.775 - 8.82 8.82 - 8.854
Low: 7.833 - 7.877 7.877 - 7.91
Close: 7.951 - 8.024 8.024 - 8.08

Technical analysis

as of: 2020-02-21 4:27:47 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 10.30     One year: 12.03
Support: Support1: 7.48    Support2: 6.66
Resistance: Resistance1: 8.81    Resistance2: 10.30
Pivot: 7.60
Moving Average: MA(5): 8.05     MA(20): 7.49
MA(100): 6.53     MA(250): 4.54
MACD: MACD(12,26): 0.25     Signal(9): 0.13
Stochastic oscillator: %K(14,3): 87.11     %D(3): 86.34
RSI: RSI(14): 56.35
52-week: High: 8.81  Low: 2.10  Change(%): 208.5
Average Vol(K): 3-Month: 106006  10-Days: 108968

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ARDX has closed below upper band by 27.6%. Bollinger Bands are 39% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 24 Jan 2020 13:00:00 +0000
Double Your Money with This Biotech

Wed, 04 Dec 2019 05:33:53 +0000
ARDX Jumps On PHREEDOM Data, AXSM Is Awesome, CARA On Watch

Wed, 27 Nov 2019 02:04:41 +0000
5 Top Gainers In Healthcare Sector (HEPA, ARDX, PTI...)

Fri, 04 Oct 2019 10:15:36 +0000
New Drugs Approved In September

Tue, 10 Sep 2019 02:51:18 +0000
6 Top Gainers In Healthcare Sector (ACAD, ARDX, KOOL…)

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 65.81
Shares Float (M) 50.24
% Held by Insiders 0.68
% Held by Institutions 68.57
Shares Short (K) 3940
Shares Short P. Month (K)

Stock Financials

EPS -1.650
Book Value (p.s.) 0.780
PEG Ratio -0.16
Profit Margin
Operating Margin -3202.53
Return on Assets (ttm) -38.3
Return on Equity (ttm) -108.1
Qtrly Rev. Growth 1651.7
Gross Profit (p.s.) 0.033
Sales Per Share
EBITDA (p.s.) -1.476
Qtrly Earnings Growth
Operating Cash Flow (M) -83.78
Levered Free Cash Flow (M) -47.56

Stock Valuations

P/E -4.86
P/E Growth Ratio -0.09
P/BV 10.28
P/S 160.40
P/CF -6.30

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.